Celgene Corporation (CELG) financial statements (2021 and earlier)

Company profile

Business Address 86 MORRIS AVENUE
SUMMIT, NJ 07901
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments4,73012,0427,9706,5527,5475,6873,900
Cash and cash equivalents4,2347,0136,1704,8804,1223,2342,090
Short-term investments4965,0291,8001,6723,4252,4531,810
Receivables2,0661,9211,6211,4211,1671,061961
Inventory, net of allowances, customer advances and progress billings458541498443393340259
Inventory458541498443393340259
Prepaid expense and other current assets320
Other current assets501388779985594436
Other undisclosed current assets1,312   122593
Total current assets:9,06714,89210,8689,4019,7137,5515,534
Noncurrent Assets
Property, plant and equipment1,3671,070930814643593578
Intangible assets, net (including goodwill)24,21613,30215,25815,7376,2594,8815,143
Goodwill8,0034,8664,8664,8792,1912,0412,043
Intangible assets, net (excluding goodwill)16,2138,43610,39210,8584,0682,8403,100
Other noncurrent assets8308771,0311,101726353
Prepaid expense and other noncurrent assets479
Total noncurrent assets:26,41315,24917,21817,6537,6285,8286,201
TOTAL ASSETS:35,48030,14128,08627,05317,34013,37811,734
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2,9872,5232,1151,6181,4841,4271,100
Accounts payable418305247241198156146
Accrued liabilities2,9872,5232,1151,3779911,001776
Employee-related liabilities    285262170
Taxes payable    988
Other undisclosed accounts payable and accrued liabilities(418)(305)(247)    
Debt50135501 606545308
Derivative instruments and hedges, liabilities   535633
Estimated litigation liability  199    
Deferred revenue and credits755561292817
Deferred tax liabilities    131 0
Contract with customer, liability73
Other liabilities   271276200431
Other undisclosed current liabilities4963549015(416)(309)(200)
Total current liabilities:4,0572,9872,9591,9692,1121,9461,690
Noncurrent Liabilities
Long-term debt and lease obligation19,76915,83813,78914,2506,2661414
Long-term debt, excluding current maturities19,76915,83813,78914,2506,2661414
Liabilities, other than long-term debt5,4934,3952,2193,3222,6231,8021,709
Deferred revenue and credits342830595248
Accounts payable and accrued liabilities2,1902,490420324   
Accrued income taxes273235188
Contract with customer, liability73
Deferred compensation liability, classified   17115112799
Deferred tax liabilities, net2,7531,327 3785568051,018
Other liabilities4775441,7712,0421,581583356
Derivative instruments and hedges, liabilities   3784  
Other undisclosed noncurrent liabilities  2,5191,593(186)4,0272,626
Total noncurrent liabilities:25,26220,23318,52719,1668,7035,8434,350
Total liabilities:29,31923,22021,48621,13410,8157,7886,040
Stockholders' equity
Stockholders' equity attributable to parent6,1616,9216,5995,9196,5255,5905,694
Common stock1010109955
Treasury stock, value(26,336)(20,243)(16,281)(14,052)(10,699)(7,662)(4,823)
Additional paid in capital14,97813,80612,37811,1199,8278,6807,540
Accumulated other comprehensive income (loss)(50)28741976891594(50)
Retained earnings17,55913,06110,0748,0746,4724,4733,023
Other undisclosed stockholders' equity(6,211)(6,634)(6,180)    
Total stockholders' equity:(50)2874195,9196,5255,5905,694
Other undisclosed liabilities and equity6,2116,6346,180    
TOTAL LIABILITIES AND EQUITY:35,48030,14128,08627,05317,34013,37811,734

Income statement (P&L) ($ in millions)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues15,28113,00311,2299,2567,6706,4945,507
Revenue, net13,00311,2299,2567,6706,4945,507
Cost of revenue(1,055)(790)(897)(699)(386)(340)(299)
Cost of goods and services sold(587)(461)(438)(420)(386)(340)(299)
Other undisclosed gross profit452299414184(107)(132)(121)
Gross profit:14,67812,51210,7478,7417,1786,0225,086
Operating expenses(9,035)(7,506)(7,166)(6,302)(4,904)(4,464)(3,627)
Other undisclosed operating income (loss)(452)(299)(414)(184)245251287
Operating income:5,1914,7073,1672,2552,5191,8091,746
Nonoperating income (expense)382105(294)80(25)(74)(13)
Investment income, nonoperating451053031282215
Foreign currency transaction loss, before tax    (10)(22)(11)
Other nonoperating income (expense)337 (324)48(44)(74)(17)
Interest and debt expense(741) (500)(311)(176)(92)(63)
Income from continuing operations before equity method investments, income taxes:4,8324,8122,3732,0242,3181,6431,671
Other undisclosed income (loss) from continuing operations before income taxes (498)  102211
Income from continuing operations before income taxes:4,8324,3142,3732,0242,3271,6651,681
Income tax expense(786)(1,374)(373)(422)(328)(216)(225)
Net income available to common stockholders, diluted:4,0462,9401,9991,6022,0001,4501,456

Comprehensive Income ($ in millions)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net income:4,0462,9401,9991,6022,0001,4501,456
Other comprehensive income (loss)233(102)(349)(147)821144 
Other undisclosed comprehensive income      13
Comprehensive income, net of tax, attributable to parent:4,2792,8381,6511,4552,8211,5941,469

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: